Eli Lilly’s growth story is increasingly tied to soaring demand for its weight-loss and diabetes medicines, helped by new factories and wider launches outside the U.S. But the same concentration creates a big “what if” risk if insurers, regulators, or competitors squeeze access and pricing.Read more

Abercrombie & Fitch pushes into new markets and leans harder into online shopping, partnerships, and refreshed brands to win over younger shoppers and keep sales growing. But rising import costs, recent weakness in parts of the business, and fierce fast-fashion competition could squeeze profits if demand or online momentum cools.Read more